The Delaware Supreme Court affirmed Friday a trial court’s decision in favor of Teva Pharmaceutical Industries Ltd.'s US unit ...

The Delaware Supreme Court appeared skeptical Wednesday of arguments that a trial judge misinterpreted contract language ...

Search for a state or federal candidate to see the donors and industries that support them.

The European Union has fined Teva and its neurology unit Cephalon €60.5 million for an elaborate “pay for delay” scheme that prevented cheaper generic competition for its sleep disorder drug ...

In a Facebook post on Wednesday night, two days after the INC’s “National Rally for Peace,” the 100-year-old former Senate President challenged the INC’s supposed support of President ...

Over the last several years, Delaware courts — especially the Court of Chancery — have seen an increase in litigation involving earnout provisions in merger agreements. Each of these cases ...

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

1 Day GOOGL 1.13% DJIA -0.32% S&P 500 -0.29% Technology -0.24% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the ...

The results of this study show that the absorption profile of FBT is similar in patients with and without mild oral mucositis, suggesting there is no need to adjust the dose of FBT when mild oral ...

Background and objectives: Patients with cancer, particularly those undergoing chemotherapy or radiotherapy, may develop oral mucositis. This is the first study to investigate the absorption ...

Other frequent patentees included Takeda, Cephalon, Roche, and Abbott Labs. On the defence side, the report identified Sandoz as the most frequent participant, with 422 cases as a defendant.

Companies on the 2023 Inc. 5000 are ranked according to percentage revenue growth from 2019 to 2022. To qualify, companies must have been founded and generating revenue by March 31, 2019.